Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma-Reference-Cited by-同舟云学术

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

Published:2018-10-31 Issue:1 Volume:120 Page:109-114
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Goeppert Benjamin,Roessler Stephanie,Renner Marcus,Singer Stephan,Mehrabi Arianeb,Vogel Monika Nadja,Pathil Anita,Czink Elena,Köhler Bruno,Springfeld Christoph,Pfeiffenberger Jan,Rupp Christian,Weiss Karl Heinz,Schirmacher Peter,von Knebel Doeberitz Magnus,Kloor Matthias

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0199-2.pdf

Reference25 articles.

1. Le, D. T. et al. Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357, 409–413 (2017).

2. Banales, J. M. et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261–280 (2016).

3. Chan, E. & Berlin, J. Biliary tract cancers: understudied and poorly understood. J. Clin. Oncol. 33, 1845–1848 (2015).